Estimates were made for 38 countries and territories in the IDF Western Pacific (WP) Region. For this edition of the IDF Diabetes Atlas, 41 data sources from 28 countries were used to generate estimates of diabetes in adults aged 20-79 years. Estimates for China, Indonesia, Malaysia and Marshall Islands were based on studies conducted within the past five years.
The WP Region accounts for over a third (38%) of the total number of adults living with diabetes. WP Region has the third highest prevalence of diabetes (11.9%) in the world. IDF projects that the number of people with diabetes in WP Region will increase 27% reaching 260 million by 2045 and the prevalence of diabetes will increase 21% reaching 14.4% in 2045. The proportion of undiagnosed diabetes is second highest in the WP Region with 52.9%. Diabetes is responsible for 2.3 million deaths in 2021, which is the highest number of all IDF Regions. Diabetes-related expenditure in 2021 totals USD241 billion, representing 25% of global expenditure.
| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 44,097.9 | 131,895.1 | 205,640.2 | 238,300.0 | 260,200.0 |
| Age-adjusted comparative prevalence of diabetes, % | 3.6 | 8.3 | 9.9 | 10.9 | 11.5 |
| People with undiagnosed diabetes, in 1,000s | - | - | 108,669.6 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 52.8 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 84,900.0 | 252,984.2 | 280,900.0 | 291,800.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 5.4 | 12.9 | 13.7 | 14.0 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 49,729.7 | 54,100.0 | 56,000.0 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 2.5 | 2.7 | 2.7 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 1,708,300.0 | 2,281,732.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 9.2 | 5.0 | 9.1 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 11.6 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 45.0 | 30.7 | 58.9 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 107.9 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 3,897,807.7 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 14.0 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 473,300.5 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 362,666.4 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | 72,200.0 | 241,313.1 | 248,980.6 | 257,300.0 |
| Total diabetes-related health expenditure, ID million | - | - | 428,362.5 | 449,616.4 | 470,772.0 |
| Diabetes-related health expenditure per person, USD | - | 1,169.9 | 1,203.8 | 30,913.4 | 31,896.8 |
| Diabetes-related health expenditure per person, ID | - | - | 2,136.9 | 102,596.3 | 108,212.6 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 1,219,457.0 | 1,544,000.0 | 1,731,706.0 | 1,806,894.5 | 1,810,000.0 |
| Population of children (0-14 y), in 1,000s | 527,666.0 | - | 464,321.5 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 616,185.8 | - | - |